MENLO PARK, Calif.--(BUSINESS WIRE)--Ionpath, a leader in high-definition spatial proteomics, today announced the launch of MIBIslide™ Blue, a groundbreaking advancement in multimodal imaging.

Clinical trial data demonstrates how Bio-Techne's spatial biology technology and Nucleai's AI-powered multimodal platforms can identify predictive biomarkers in immunotherapy and targeted ...

The G4X Early Access Program is currently underway at Beth Israel Deaconess Medical Center and Vanderbilt University Medical Center, providing valuable feedback highlighting the platform’s real-world ...

ILMN's Connected Multiomics, launched after early user input, advances precision health research and may boost the stock.